NGL Fine-Chem Limited — PPTs, 10-02-2026: Investor Presentation

NGL Fine-Chem delivered a strong Q3FY26, with revenue growing 43.11% YoY to ₹127.51 Cr, driven by higher volumes. Profitability significantly improved, with EBITDA surging 337.81% YoY to ₹22.31 Cr (17.50% margin) and PAT up 1,129.12% YoY to ₹15.69 Cr, due to easing raw material costs and operational efficiencies. Animal APIs contributed 92% of revenue.

The company's brownfield expansion is complete, with commercial production started. Its greenfield expansion at Tarapur is on track for Phase II commissioning in Q1FY27 and commercial production from H2 FY27. Total investment for this project is revised to ₹210 Cr, funded by a mix of debt and internal accruals. NGL Fine-Chem also made substantial progress on regulatory filings, securing multiple approvals for controlled markets. Management sees firm demand and healthy traction, expecting efficiency gains to strengthen margins and is confident in sustaining growth.